Copertina

Bioinformatics‐based identification of hepatocellular carcinoma‐associated hub genes and assessment of the restorative effect of tannic acid in rat liver exposed to monosodium glutamate

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Hilal Tosun, Habibe Karadas, Hamid Ceylan
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Cancer Medicine
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Identification of dilated cardiomyopathy‐linked key genes by bioinformatics methods and evaluating the impact of tannic acid and monosodium glutamate in rats
di: Habibe Karadas, et al.
Pubblicazione: (2024)

Correction to “The adverse characteristics of hepatocellular carcinoma in the non‐cirrhotic liver disproportionately disadvantage black patients”
Pubblicazione: (2024)

Identification of pyroptosis subtypes and prognosis model of hepatocellular carcinoma based on pyroptosis‐related genes
di: Haisheng Xie, et al.
Pubblicazione: (2024)

Anatomic versus non‐anatomic liver resection for hepatocellular carcinoma—A European multicentre cohort study in cirrhotic and non‐cirrhotic patients
di: Jasmin Zeindler, et al.
Pubblicazione: (2024)

Association between novel genetic variants of Notch signaling pathway genes and survival of hepatitis B virus‐related hepatocellular carcinoma
di: Liming Qin, et al.
Pubblicazione: (2024)

Impact of inflammation and the immune system on hepatocellular carcinoma recurrence after hepatectomy
di: Sha She, et al.
Pubblicazione: (2024)

Quercetin‐induced degradation of RhoC suppresses hepatocellular carcinoma invasion and metastasis
di: Chunlong Huang, et al.
Pubblicazione: (2024)

Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma
di: Takahiro Kinami, et al.
Pubblicazione: (2024)

Real world data of cabozantinib in patients with hepatocellular carcinoma: Focusing on dose setting and modification
di: Hironao Okubo, et al.
Pubblicazione: (2024)

Identification of molecular characteristics of hepatocellular carcinoma with microvascular invasion based on deep targeted sequencing
di: Linlin Zheng, et al.
Pubblicazione: (2024)

Similar usage of T‐cell receptor β‐chain between tumor and adjacent normal tissue in hepatocellular carcinoma
di: Jie‐Zuan Yang, et al.
Pubblicazione: (2024)

A clinical‐radiomic‐pathomic model for prognosis prediction in patients with hepatocellular carcinoma after radical resection
di: Qu Xie, et al.
Pubblicazione: (2024)

Feasibility of atezolizumab and bevacizumab combination regimens in patients with hepatocellular carcinoma and lung cancer taking direct oral anticoagulants
di: Tasuku Nakabori, et al.
Pubblicazione: (2024)

Risk factors for lenvatinib‐induced palmar‐plantar erythrodysesthesia syndrome in patients with hepatocellular carcinoma: A retrospective study
di: Shusuke Uekusa, et al.
Pubblicazione: (2024)

A polygenetic risk score combined with environmental factors better predict susceptibility to hepatocellular carcinoma in Chinese population
di: Yuanlin Zou, et al.
Pubblicazione: (2024)

Outcomes of hepatocellular carcinoma patients treated in the lenvatinib and immunotherapy era (2018–2021) compared to the sorafenib era (2008–2018)
di: Chloe A. Lim, et al.
Pubblicazione: (2024)

Deep learning‐based accurate diagnosis and quantitative evaluation of microvascular invasion in hepatocellular carcinoma on whole‐slide histopathology images
di: Xiuming Zhang, et al.
Pubblicazione: (2024)

Efficacy and prognostic factors of COVID‐19 vaccine in patients with hepatocellular carcinoma: Analysis of data from a prospective cohort study
di: He Zhao, et al.
Pubblicazione: (2024)

Association of serum AFP trajectories and hepatocellular carcinoma outcomes after hepatic arterial infusion chemotherapy: A longitudinal, multicenter study
di: Chao An, et al.
Pubblicazione: (2024)

Exploring the factors affecting the occurrence of postoperative MVI and the prognosis of hepatocellular carcinoma patients treated with hepatectomy: A multicenter retrospective study
di: Jilin Yang, et al.
Pubblicazione: (2024)

The m6A methyltransferase METTL5 promotes neutrophil extracellular trap network release to regulate hepatocellular carcinoma progression
di: Qi Wang, et al.
Pubblicazione: (2024)

Expression of PTGS2 along with genes regulating VEGF signalling pathway and association with high‐risk factors in locally advanced oral squamous cell carcinoma
di: Mehta Vedant Kamal, et al.
Pubblicazione: (2024)

Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein‐1 inhibitors: A promising treatment approach for high‐burden hepatocellular carcinoma
di: Shumin Fu, et al.
Pubblicazione: (2024)

No lipiodol, no beads—another transcatheter arterial chemoembolization (TACE) with fine cisplatin powder and porous gelatin particles for TACE‐naïve, multifocal, up‐to‐seven out hepatocellular carcinoma
di: Rui Sato, et al.
Pubblicazione: (2024)

Identification of Anoikis‐Related Genes in Gastric Cancer: Bioinformatics and Experimental Validation
di: Chao Song, et al.
Pubblicazione: (2025)

Bioinformatics Analysis and Experimental Validation of ASF1B in Breast Tumors
di: Wenhao Xing, et al.
Pubblicazione: (2025)

Early identification of severe immune checkpoint inhibitor associated myocarditis: From an electrocardiographic perspective
di: Yongyin Gao, et al.
Pubblicazione: (2024)

Heterogeneity‐induced NGF‐NGFR communication inefficiency promotes mitotic spindle disorganization in exhausted T cells through PREX1 suppression to impair the anti‐tumor immunotherapy with PD‐1 mAb in hepatocellular carcinoma
di: Xin Wang, et al.
Pubblicazione: (2024)

Prediction for oxaliplatin‐induced liver injury using patient‐derived liver organoids
di: Kumiko Tatsumi, et al.
Pubblicazione: (2024)

Correction to Fat mass and obesity‐associated protein regulates tumorigenesis of arecoline‐promoted human oral carcinoma
Pubblicazione: (2024)

Correction to “Bioinformatics Identification of Lactate‐Associated Genes in Hepatocellular Carcinoma: G6PD 's Role in Immune Modulation”
Pubblicazione: (2025)

Notch signaling genes and CD8+ T‐cell dynamics: Their contribution to immune‐checkpoint inhibitor therapy in oral squamous cell carcinoma: A retrospective study
di: Kazuhiro Ogi, et al.
Pubblicazione: (2024)

DEPDC1B: A novel tumor suppressor gene associated with immune infiltration in colon adenocarcinoma
di: Dandan Zhu, et al.
Pubblicazione: (2024)

Genetic variants in primary cilia‐related genes associated with the prognosis of first‐line chemotherapy in colorectal cancer
di: Lei Qiu, et al.
Pubblicazione: (2024)

Epigenome‐wide association study of prostate cancer in African American men identified differentially methylated genes
di: Anders Berglund, et al.
Pubblicazione: (2024)

Neoadjuvant chemoimmunotherapy was associated with better short‐term survival of patients with locally advanced esophageal squamous cell carcinoma compared to neoadjuvant chemoradiotherapy
di: Xiaofeng Duan, et al.
Pubblicazione: (2024)

Molecular complexity of intraductal carcinoma of the prostate
di: Sha Zhu, et al.
Pubblicazione: (2024)

Association of county level poverty with mortality from primary liver cancers
di: Matthew Ledenko, et al.
Pubblicazione: (2024)

Is conventional functional liver remnant volume higher than 40% still sufficient to prevent post‐hepatectomy liver failure in jaundiced patients with hilar cholangiocarcinoma? A single‐center experience in China
di: Tian‐Run Lv, et al.
Pubblicazione: (2024)

Correction to “Dose‐dependent effects of calorie restriction on gene expression, metabolism, and tumor progression are partially mediated by insulin‐like growth factor‐1”
Pubblicazione: (2024)